Shift in Site of Care for Oncology Has Affected the Marketplace for Oncology Drugs

coapharm2017-12-15T14:02:38+00:00December 15, 2017|

Lawmakers battle Trump, PhRMA on discount drug rule

coapharm2017-12-15T14:01:28+00:00December 15, 2017|

Follow the money to understand how drug profits flow

coapharm2017-12-15T13:58:15+00:00December 15, 2017|

Well-Meaning Drug Discount Program Encourages Hospitals to Profit Rather than Effectively Serve Poor

coapharm2017-12-14T14:03:13+00:00December 14, 2017|

California, North Carolina, and New York Will See the Largest Provider Payment Cuts and Beneficiary Savings due to 340B Program Changes

coapharm2017-12-14T14:01:31+00:00December 14, 2017|

Hospitals see growing 340B profits on cancer drugs: 4 findings

coapharm2017-12-13T14:54:37+00:00December 13, 2017|

Congress Must Reform The Broken 340B Program

coapharm2017-12-13T14:53:30+00:00December 13, 2017|

Experts Tell Congress How To Cut Drug Prices. We Give You Some Odds.

coapharm2017-12-13T14:42:47+00:00December 13, 2017|

Should HHS Negotiate Prescription Drug Prices?

coapharm2017-12-13T14:30:42+00:00December 13, 2017|

Congress Must Reform the Broken 340B Program

coapharm2017-12-12T14:48:59+00:00December 12, 2017|